Abstract:The ligand 2-['2-(4,5-dimethyl thiazolyl)azo]-imidazole (DMeTAI), which is generated from 2-amino-4,5-dimethylthiazol and imidazole, was used to synthesize coordination compounds containing Ni(II) and Cu(II) ions. To confirm the structure of the synthesized chelates, a range of analytical techniques were used, including thermal analysis, X-ray powder diffraction, infrared spectroscopy, mass spectrometry, magnetic susceptibility analysis, microanalysis, and 1 H NMR. The complexes have the formula [M(L) 2 ]Cl 2 .H 2 O, where M stands for Ni(II) or Cu(II), and the results showed that the metal ion–ligand ratio was 1:2. Molar conductivity results demonstrated that the complexes are all electrolytes that fall within a certain range 77.01–83.56 Ω −1 cm 2 mol −1 , and the magnetic susceptibility measurements indicated an octahedral structural geometry for the complexes. Besides, the central metal ion interacts with the ligand as a tridentate (N,N,N) coordination by the (C=N) nitrogen atom from the thiazole moiety, the (N=N) nitrogen atom from the azo group, and the (C=N) nitrogen atom from the imidazole moiety. Thermal analysis (TG/DTG) showed that the thermal decomposition of the obtained compounds is a multi-stage process depending on the metal ion and atmosphere in which was conducted. Computational methods were subsequently utilized to delve more deeply into the properties of both the ligand and metallic complexes. The structural formulas of the examined azo dye ligand and metal complexes were optimized using the Gaussian09 program. Additionally, the DFT/B3LYP method was employed to compute energy gaps and other pertinent theoretical parameters. Molecular docking using the MOE 2015 program was utilized to explore the interactions of the compounds with the human p110alpha/p85alpha complex (PDB ID: 2RD0), which is associated with ovarian carcinoma. We determined the energies of hydrophobic and hydrogen bonding from the analysis of the docked protein receptors. In addition to the theoretical investigations, both the ligand and metallic complexes were evaluated for their effectiveness as antibacterial agents against Staphylococcus aureus (Gram-positive), Escherichia coli (Gram-negative), and the antifungal strain Penicillium sp. The findings revealed that the ligand and its metallic complexes demonstrated moderate antimicrobial efficacy against both Gram-positive and Gram-negative microbes, surpassing the standard drugs Ciprofloxacin and Cycloheximide. Additionally, the cytotoxicity of the ligand was assessed against human ovarian carcinoma cancer cells (SKOV-3). Furthermore, in silico ADMET analysis predicted favourable pharmacokinetic and toxicity profiles for the synthesized molecules, indicating promising oral drug-like properties and a nontoxic nature.

Synthesis and Characterization Some Transition Metal Complexes of New Ligand Chalcone-Azo Derivatives from P-methoxy-4, 5-diphenyl Imidazole and Study Biological Effect of Pd(II) Complex

Preparation, Characterization of Some Metal Complexes of New Mixed Ligands Derived from 5-Methyl Imidazole and Study the Biological Activity of Palladium (II) Complex as Anticance

Palladium(II) Complexes with N,N′-Dialkyl-1,10-phenanthroline-2,9-dimathanamine: Synthesis, Characterization and Cytotoxic Activity

Biological Impact of Pd (II) Complexes: Synthesis, Spectral Characterization, In Vitro Anticancer, CT-DNA Binding, and Antioxidant Activities

Exploration on Synthesis, Characterization and Biological Activities of Transition Metal Complexes Comprising Hydroxybenzylideneaminocyclohexylimino-methyl-4,6-dibromophenol Schiff Base Ligand

Synthesis, characterization, PXRD studies, and theoretical calculation of the effect of gamma irradiation and antimicrobial studies on novel Pd(II), Cu(II), and Cu(I) complexes

Synthesis, and characterization of Ni(II), and Cu(II) metal complexes containing new azo dye ligand (N,N,N) and evaluation of their biological activities supported by DFT studies, molecular docking, ADMET profiling, drug-likeness analysis and toxicity prediction

Crystal Structure, Anticancer, and Antimicrobial Evaluation of a Novel Substituted Pyrazole Ligand and Its Co(II), Ni(II), and Zn(II) Complexes

Computational and experimental examinations of new antitumor palladium(II) complex: CT-DNA-/BSA-binding, in-silico prediction, DFT perspective, docking, molecular dynamics simulation and ONIOM

Spectroscopic inspection, DFT analysis, biological evaluation and molecular docking studies of new 2-(phenylamino)acetohydrazide hydrazone based- transition metal complexes

Physico-Chemical Study of Mn(II), Co(II), Cu(II), Cr(III), and Pd(II) Complexes with Schiff-Base and Aminopyrimidyl Derivatives and Anti-Cancer, Antioxidant, Antimicrobial Applications

Synthesis of New Naphthyl Aceto Hydrazone-Based Metal Complexes: Micellar Interactions, DNA Binding, Antimicrobial, and Cancer Inhibition Studies

Comparative Linkage of Novel Anti-Tumor Pd(II) Complex with Bio-Macromulecules: Fluorescence, UV-Vis, DFT, Molecular Docking and Molecular Dynamics Simulation Studies

Synthesis, spectro-themal characterization, DFT calculations and biochemical evaluation of a newly synthesized tridentate Schiff base transition metal complexes

New Ligand-Based Metal Complexes: Synthesis, Spectroscopic Characterization, Thermal Behavior, Anticancer Properties, and Biological Activity

Preparation, Characterization, Antioxidant and Antibacterial Studies of New Metal (II) Complexes with Schiff Base for 3-amino-1-phenyl-2- pyrazoline-5-one

Preparation, characterization, and computational study on transition metal complexes derived from thiophene Schiff base and evaluation of their cytotoxicity against hepatic cell line, antioxidant activities, and ligand's anticorrosive properties

Synthesis, characterization and biological activity studies of Pd(II) and Pt(II)–2H-benzo[e][1,3]oxazine-2,4(3H)-dione (HBzoxe) complexes

Synthesis, Characterization, Antimicrobial, DNA Cleavage and Fluorescent Activity of Metal ion(II) Coordinate with 2H-Chromene Azo novel ligand

Theoretical studies and evaluation of anticancer properties of two cobalt(III) Schiff base complexes derived from 3,5-dichloro-2-hydroxybenzaldehyde and 1,2-phenylene diamine

Innovation of some novel complexes based on 1‐(4‐nitrophenyl)‐1H‐1,2,3‐triazol‐4‐yl)methanol ligand: Synthesis, structural elucidation DFT calculation and pharmaceutical studies